Search for:
Category

Covid-19

Category

Countries around the globe are facing unprecedented and rapid change due to the COVID-19 pandemic. The Government Intervention Schemes Guide provides a summary of key government intervention measures across jurisdictions around the globe in relation to: Foreign Investment Restrictions Debt Equity Taxation EU State Aid Approvals (where relevant) READ REPORT…

Regulatory enforcement of consumer protection law in the UK is changing, even if the UK won’t be implementing the EU’s New Deal for Consumers (New Deal). Enhancements to existing laws are set to give the Competition and Markets Authority (CMA) more tools that it can use to encourage – or force – businesses to comply. 

Currently the CMA’s powers are relatively limited when it comes to consumer enforcement (compared to those available to privacy and competition regulators, for instance). Whilst the future is uncertain, recent action taken by the CMA indicates an increased willingness on the part of the regulator to take interventionist (and in some cases, aggressive) action. 

In this article we draw on our experience engaging with the CMA on consumer protection matters – and consider how changes to the legislative framework and leadership at the CMA are likely to impact its approach.

With judgement No. 6345 of October 20, 2020, the Council of State ruled on the lawfulness of a tender procedure for the supply of medical devices and, in particular, on the assessment made by the competent contracting authority that, after having reviewed the technical documentation submitted by the successful bidder, considered the products offered by the latter to be fully equivalent to those requested.

The fund industry has absorbed many regulatory reforms in a decade, most notably with the AIFMD first and the increased level of risk management, monitoring and reporting required from both legislators and professional investors. From a very liberal world of real estate private equity investment in the 2000s to the…